Natural acquisition and spontaneous elimination of Helicobacter pylori infection : Clinical implicationsXIA, H. H.-X; TALLEY, N. J.The American journal of gastroenterology. 1997, Vol 92, Num 10, pp 1780-1787, issn 0002-9270Article

Helicobacter pylori eradication in patients with non-ulcer dyspepsiaXIA, H. H.-X; TALLEY, N. J.Drugs (Basel). 1999, Vol 58, Num 5, pp 785-792, issn 0012-6667Article

Helicobacter pylori infection, reflux esophagitis, and atrophic gastritis : An unexplored triangleXIA, H. H.-X; TALLEY, N. J.The American journal of gastroenterology. 1998, Vol 93, Num 3, pp 394-400, issn 0002-9270Article

Double-blind, randomized controlled study to assess the effects of lansoprazole 30 mg and lansoprazole 15 mg on 24-h oesophageal and intragastric pH in Chinese subjects with gastro-oesophageal reflux diseaseWONG, W. M; LAI, K. C; LAM, S. K et al.Alimentary pharmacology & therapeutics. 2004, Vol 19, Num 4, pp 455-462, issn 0269-2813, 8 p.Article

Metronidazole- and clarithromycin-resistant Helicobacter pylori in dyspeptic patients in western Sydney as determined by testing multiple isolates from different gastric sitesXIA, H. H.-X; KALANTAR, J; TALLEY, N. J et al.Journal of gastroenterology and hepatology. 1998, Vol 13, Num 10, pp 1044-1049, issn 0815-9319Article

Trends in the prevalence of peptic ulcer disease and Helicobacter pylori infection in family physician-referred uninvestigated dyspeptic patients in Hong KongXIA, B; XIA, H. H. X; WONG, B. C. Y et al.Alimentary pharmacology & therapeutics. 2005, Vol 22, Num 3, pp 243-249, issn 0269-2813, 7 p.Article

Twenty-minute 50 mg ¹³C-urea breath test without test meal for the diagnosis of Helicobacter pylori infection in ChineseWONG, W. M; WONG, B. C. Y; LI, T. M et al.Alimentary pharmacology & therapeutics. 2001, Vol 15, Num 9, pp 1499-1504, issn 0269-2813Article

Randomized controlled study of rabeprazole, levofloxacin and rifabutin triple therapy vs. quadruple therapy as second-line treatment for Helicobacter pylori infectionWONG, W. M; GU, Q; WONG, B. C. Y et al.Alimentary pharmacology & therapeutics. 2003, Vol 17, Num 4, pp 553-560, issn 0269-2813, 8 p.Article

An evaluation of a rapid urine test for the diagnosis of Helicobacter pylori infection in the Chinese populationWONG, W. M; WONG, B. C. Y; XIA, H. H. X et al.Alimentary pharmacology & therapeutics. 2002, Vol 16, Num 4, pp 813-817, issn 0269-2813Article

One-week omeprazole, furazolidone and amoxicillin rescue therapy after failure of Helicobacter pylori eradication with standard triple therapiesWONG, W. M; WONG, B. C. Y; LAM, S. K et al.Alimentary pharmacology & therapeutics. 2002, Vol 16, Num 4, pp 793-798, issn 0269-2813Article

Upper gastrointestinal evaluation of Chinese patients with non-cardiac chest painWONG, W.-M; LAI, K. C; LAU, C. P et al.Alimentary pharmacology & therapeutics. 2002, Vol 16, Num 3, pp 465-471, issn 0269-2813Article

Long-term prospective follow-up of endoscopic oesophagitis in southern Chinese: prevalence and spectrum of the diseaseWONG, W.-M; LAM, S. K; WONG, B. C. Y et al.Alimentary pharmacology & therapeutics. 2002, Vol 16, Num 12, pp 2037-2042, issn 0269-2813, 6 p.Article

Evaluation of anti-helicobacter pylori IgG2 antibody for the diagnosis of Helicobacter pylori infection in western and Chinese populationsREN, Z; BORODY, T; PANG, G et al.Alimentary pharmacology & therapeutics. 2005, Vol 21, Num 1, pp 83-89, issn 0269-2813, 7 p.Article

Onset and disappearance of reflux symptoms in a Chinese population: a 1-year follow-up studyWONG, W. M; LAI, K. C; WONG, B. C. Y et al.Alimentary pharmacology & therapeutics. 2004, Vol 20, Num 7, pp 803-812, issn 0269-2813, 10 p.Article

Symptomatic response to lansoprazole predicts abnormal acid reflux in endoscopy-negative patients with non-cardiac chest painXIA, H. H. X; LAI, K. C; WONG, B. C. Y et al.Alimentary pharmacology & therapeutics. 2003, Vol 17, Num 3, pp 369-377, issn 0269-2813, 9 p.Article

Prevalence, clinical spectrum and health care utilization of gastro-oesophageal reflux disease in a Chinese population: a population-based studyWONG, W. M; LAI, K. C; WONG, B. C. Y et al.Alimentary pharmacology & therapeutics. 2003, Vol 18, Num 6, pp 595-604, issn 0269-2813, 10 p.Article

Safety and radiation-enhancing effect of sodium glycididazole in locoregionally advanced laryngeal cancers previously treated with platinum-containing chemotherapy regimens: A preliminary reportZENG, Y. C; WU, R; CHI, F et al.Cancer radiothérapie. 2010, Vol 14, Num 1, pp 59-64, issn 1278-3218, 6 p.Article

A rapid-release 50-mg tablet-based ¹³C-urea breath test for the diagnosis of Helicobacter pylori infectionWONG, W. M; LAM, S. K; LAI, K. C et al.Alimentary pharmacology & therapeutics. 2003, Vol 17, Num 2, pp 253-257, issn 0269-2813, 5 p.Article

A validated symptoms questionnaire (Chinese GERDQ) for the diagnosis of gastro-oesophageal reflux disease in the Chinese populationWONG, W. M; LAM, K. F; LAM, S. K et al.Alimentary pharmacology & therapeutics. 2003, Vol 17, Num 11, pp 1407-1413, issn 0269-2813, 7 p.Article

One-week ranitidine bismuth citrate, amoxicillin and metronidazole triple therapy for the treatment of Helicobacter pylori infection in ChineseHUNG, W. K; WONG, W. M; FUNG, F. M. Y et al.Alimentary pharmacology & therapeutics. 2002, Vol 16, Num 12, pp 2067-2072, issn 0269-2813, 6 p.Article

Review article : 'true' re-infection of Helicobacter pylori after successful eradication -worldwide annual rates, risk factors and clinical implicationsZHANG, Y.-Y; XIA, H. H.-X; ZHUANG, Z.-H et al.Alimentary pharmacology & therapeutics. 2009, Vol 29, Num 2, pp 145-160, issn 0269-2813, 16 p.Article

Helicobacter pylori infection and non-ulcer dyspepsiaTALLEY, N. J; XIA, H. H.-X.British medical bulletin. 1998, Vol 54, Num 1, pp 63-69, issn 0007-1420Article

Can Helicobacter pylori serology still be applied as a surrogate marker to identify peptic ulcer disease in dyspepsia?XIA, H. H.-X; KALANTAR, J. S; MITCHELL, H. M et al.Alimentary pharmacology & therapeutics. 2000, Vol 14, Num 5, pp 615-624, issn 0269-2813Article

Increased epithelial and serum expression of macrophage migration inhibitory factor (MIF) in gastric cancer : potential role of MIF in gastric carcinogenesisHE, X.-X; YANG, J; DING, Y.-W et al.Gut. 2006, Vol 55, Num 6, pp 797-802, issn 0017-5749, 6 p.Article

Effect of Helicobacter pylori on apoptosis and apoptosis related genes in gastric cancer cellsYANG, Y; DENG, C. S; PENG, J. Z et al.MP. Molecular pathology. 2003, Vol 56, Num 1, pp 19-24, issn 1366-8714, 6 p.Article